SynthesisNeurosurgical review2025
Impact of social factors on outcomes following pediatric neuro-oncology surgery in the United States: a systematic review and meta-analysis.
Synthesis in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To use AI-assisted software to identify gender, racial, and socioeconomic differences in post-operative outcomes following pediatric neuro-oncology surgery. PubMed, Scopus, Web of Science, and Ovid were queried using a semi-automated software. Meta-analyses quantified pooled odds ratios for overall survival (OS), gross total resection (GTR), recurrence, 30-day readmission, medical complications (neurologic and endocrinologic), and surgical complications. Where possible, subanalyses were performed based on study type and cranial tumor location. Sixty-seven studies were included. Across all studies, white children had greater OS (OR 0.70, 95% CI [0.55, 0.88]) and GTR (OR 0.86, 95% CI [0.78, 0.93]), while non-white children more often had a medical complication (OR 1.33, 95% CI [1.01, 1.76]). Those with government insurance (OR 1.72, 95% CI [1.01, 2.92]) or lower household income (OR 1.25, 95% CI [1.10, 1.42]) had higher 30-day readmission rates. Patients treated at a small-volume facility had lower rates (OR 0.80, 95% CI [0.71, 0.91]). Subanalyses of case series showed female patients were at higher risk of endocrinologic complications (OR 2.56, 95% CI [1.17, 5.64]), namely hypopituitarism (OR 3.29, 95% CI [1.10, 9.86]). In cohort studies, female patients more often experienced diabetes insipidus (OR 2.22, 95% CI [1.20, 4.08]). Non-white, government-insured, lower-income, and female patients are more likely to experience an adverse event. This study identifies the importance of considering demographic variables during pre-operative risk assessment. Our findings warrant further subgroup analyses across varying tumor locations and types to elucidate parameters contributing to these disparities and explore interventions.
Indexed as
Identifiers
40148684What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.